AIMOVIG FDA approval date

The FDA approved AIMOVIG on 17 May 2018.

FDA approval date
17 May 2018

Drug identity has not yet been verified against registry records

Also recorded as ERENUMAB-AOOE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-05-17DayAIMOVIGFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761077", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["AIMOVIG"], "active_ingredients": ["ERENUMAB-AOOE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180517", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026